Home ROVI acquires rights to Dexchlorpheniramine Maleate in the Spanish and French markets

ROVI acquires rights to Dexchlorpheniramine Maleate in the Spanish and French markets

Find out more …

General Information
of the Company
Financial and
Economic Information
Corporate Governance
Information for Investors
Contact
Read time: 0 mins
ROVI acquires rights to Dexchlorpheniramine Maleate in the Spanish and French markets
https://rovi.es/sites/default/files/PR_Polaramine_0.pdf
Year: 
2019